People: NuVasive Inc (NUVA.O)

NUVA.O on Nasdaq

22.34USD
18 Jun 2013
Price Change (% chg)

$0.19 (+0.86%)
Prev Close
$22.15
Open
$22.16
Day's High
$22.57
Day's Low
$21.88
Volume
277,891
Avg. Vol
350,939
52-wk High
$25.99
52-wk Low
$12.35

Search Stocks

Valentine, Keith 

Brief Biography

Mr. Keith C. Valentine is President, Chief Operating Officer of NuVasive, Inc. He has served as President and Chief Operating Officer since January 2007. Between December 2004 and January 2007, he served as President, and between January 2002 and December 2004, he served as Executive Vice President. Prior to that, he served as Sr. Vice President of Marketing and Development. With over 20 years of experience in the orthopaedic industry, Mr. Valentine has served as Vice President of Marketing at ORATEC Interventions, Inc., a medical device company which was later acquired by Smith & Nephew plc and served in various capacities at Medtronic Sofamor Danek during his eight years with the company, including Vice President of Marketing for the Rods Division and Group Director for the BMP Biologics program, the Interbody Sales Development effort and International Sales and Marketing. Mr. Valentine currently serves as a director of California Healthcare Institute. Mr. Valentine received a B.B.A. in Management and Biomedical Sciences from Western Michigan University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
525,000 -- 2,212,140 3,182,540

Options Compensation

  Quantity Market Value
Excercisable 155,000 1,903,880.00
Unexercisable 72,500 623,500.00
Excercised 28,000 867,789.00
Name Fiscal Year Total

Alexis Lukianov

6,148,370

Keith Valentine

3,182,540

Michael Lambert

2,137,650

Patrick Miles

2,528,480

Jason Hannon

1,993,080

Scott Durall

--
As Of 30 Dec 2011
Search Stocks